News
WY Biotech is now obligated to pay a $7 million upfront license fee to HCW Biologics by Sept. 30, according to a filing with the Securities and Exchange Commission. HCW Biologics previously said it ...
As global markets navigate a muted response to new U.S. tariffs and mixed economic signals, the Asian tech sector remains a focal point for investors seeking high growth opportunities. With market ...
Stocks like Wipro, Axis Bank, LTIMindtree, Indian Hotels, Lupin, Tracxn Technologies, Capital Small Finance Bank, Veranda ...
2d
Investor's Business Daily on MSNArcutis Stock Awaits Next Move In A Base; Its Skin Drug Sales Grew 196%On May 6, Arcutis reported first-quarter results showed loss of 20 cents a share, which slightly beat estimates. Its sales ...
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...
Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...
Alphabet, UnitedHealth Group, Oracle, ServiceNow, and GE Aerospace are the five Healthcare stocks to watch today, according ...
Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.
Shares of the copper mining company advanced 2.5% after President Trump announced that [a 50% tariff was coming]( ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results